Laboratory reflex testing strategy for the early identification of primary care patients with multiple myeloma

IF 2.5 3区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Clinical biochemistry Pub Date : 2024-02-21 DOI:10.1016/j.clinbiochem.2024.110730
Maria Salinas , Emilio Flores , Alvaro Blasco , Maite Lopez-Garrigós , Ruth Torreblanca , María Leiva-Salinas , Irene Gutierrez , Carlos Leiva-Salinas , On behalf of the PRIMary Care-LABoratory (PRIMLAB) working group
{"title":"Laboratory reflex testing strategy for the early identification of primary care patients with multiple myeloma","authors":"Maria Salinas ,&nbsp;Emilio Flores ,&nbsp;Alvaro Blasco ,&nbsp;Maite Lopez-Garrigós ,&nbsp;Ruth Torreblanca ,&nbsp;María Leiva-Salinas ,&nbsp;Irene Gutierrez ,&nbsp;Carlos Leiva-Salinas ,&nbsp;On behalf of the PRIMary Care-LABoratory (PRIMLAB) working group","doi":"10.1016/j.clinbiochem.2024.110730","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Our objective was to shorten the screen for multiple myeloma (MM), through reflex testing.</p></div><div><h3>Design and Methods</h3><p>The clinical laboratory in the public University Hospital of San Juan (Alicante, Spain), serves 234,551 inhabitants. Through an intervention agreed with general practitioners, the Laboratory Information System (LIS) automatically registered serum immunoglobulins (Ig) when serum total proteins (STP) &gt; 80 g/L for the first time in primary care patients. When concomitantly one Ig presented a value above and one below its reference interval, the LIS automatically registered a serum protein electrophoresis (SPEP). When a monoclonal peak in SPEP, immunofixation electrophoresis (IFE) for the typification of monoclonal bands (MB) was performed. If MB were present, a comment in the report explained the intervention. The number of additionally registered Ig, SPEP, IFE, and new diagnosis of MM were counted. The number of days elapsed from the report of elevated STP result to the final MM diagnosis was also counted as median and interquartile range (IQR), and compared to a pre intervention period.</p></div><div><h3>Results</h3><p>2071 cases of hyperproteinemia were identified, and had 91 a monoclonal peak, confirmed by IFE. In 35 patients it was a new finding, and 9 were diagnosed with MM, 3 Waldestrom macroglobulinemia, 2 lymphoplasmacytic lymphoma and 21 monoclonal gammopathy of undetermined significance. The number of days elapsed from hyperproteinemia to diagnosis was lower in the intervention period (21.5 vs 119.4) (P &lt; 0.01). As our results show, in addition to shortening the time to diagnosis, an increased rate of detection of plasma cell disorders was observed when using our algorithm.</p></div><div><h3>Conclusions</h3><p>The above laboratory interventions agreed with clinicians, making use of laboratory technology resulted in early identification of MM.</p></div>","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical biochemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009912024000249","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

Our objective was to shorten the screen for multiple myeloma (MM), through reflex testing.

Design and Methods

The clinical laboratory in the public University Hospital of San Juan (Alicante, Spain), serves 234,551 inhabitants. Through an intervention agreed with general practitioners, the Laboratory Information System (LIS) automatically registered serum immunoglobulins (Ig) when serum total proteins (STP) > 80 g/L for the first time in primary care patients. When concomitantly one Ig presented a value above and one below its reference interval, the LIS automatically registered a serum protein electrophoresis (SPEP). When a monoclonal peak in SPEP, immunofixation electrophoresis (IFE) for the typification of monoclonal bands (MB) was performed. If MB were present, a comment in the report explained the intervention. The number of additionally registered Ig, SPEP, IFE, and new diagnosis of MM were counted. The number of days elapsed from the report of elevated STP result to the final MM diagnosis was also counted as median and interquartile range (IQR), and compared to a pre intervention period.

Results

2071 cases of hyperproteinemia were identified, and had 91 a monoclonal peak, confirmed by IFE. In 35 patients it was a new finding, and 9 were diagnosed with MM, 3 Waldestrom macroglobulinemia, 2 lymphoplasmacytic lymphoma and 21 monoclonal gammopathy of undetermined significance. The number of days elapsed from hyperproteinemia to diagnosis was lower in the intervention period (21.5 vs 119.4) (P < 0.01). As our results show, in addition to shortening the time to diagnosis, an increased rate of detection of plasma cell disorders was observed when using our algorithm.

Conclusions

The above laboratory interventions agreed with clinicians, making use of laboratory technology resulted in early identification of MM.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于早期识别多发性骨髓瘤初级保健患者的实验室反射测试策略。
目标:我们的目标是通过反射检测缩短多发性骨髓瘤(MM)的筛查时间:我们的目标是通过反射检测缩短多发性骨髓瘤(MM)的筛查时间:圣胡安公立大学医院(西班牙阿利坎特)的临床实验室为 234,551 名居民提供服务。通过与全科医生商定的一项干预措施,实验室信息系统(LIS)在初级保健患者的血清总蛋白(STP)首次大于 80 克/升时自动登记血清免疫球蛋白(Ig)。当一种 Ig 值同时高于和低于其参考区间时,LIS 会自动登记血清蛋白电泳 (SPEP)。当 SPEP 出现单克隆峰时,就会进行免疫固定电泳(IFE),对单克隆条带(MB)进行分型。如果出现单克隆条带,报告中的注释会对干预措施做出解释。统计额外登记的 Ig、SPEP、IFE 和新诊断为 MM 的次数。还计算了从报告 STP 结果升高到最终确诊 MM 的天数中位数和四分位数间距(IQR),并与干预前的天数进行比较。其中 35 例患者为新发现,9 例被诊断为 MM,3 例为 Waldestrom 巨球蛋白血症,2 例为淋巴浆细胞性淋巴瘤,21 例为意义不明的单克隆抗体病。在干预期间,从高蛋白血症到确诊的天数较少(21.5 对 119.4)(P 结论:在干预期间,从高蛋白血症到确诊的天数较少(21.5 对 119.4):上述实验室干预措施得到了临床医生的认同,利用实验室技术可及早发现 MM。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical biochemistry
Clinical biochemistry 医学-医学实验技术
CiteScore
5.10
自引率
0.00%
发文量
151
审稿时长
25 days
期刊介绍: Clinical Biochemistry publishes articles relating to clinical chemistry, molecular biology and genetics, therapeutic drug monitoring and toxicology, laboratory immunology and laboratory medicine in general, with the focus on analytical and clinical investigation of laboratory tests in humans used for diagnosis, prognosis, treatment and therapy, and monitoring of disease.
期刊最新文献
Challenges and Perspectives on the Adoption of Cystatin C testing in China: A laboratory technician’s perspective Quantitative evaluation of adalimumab and anti-adalimumab antibodies in sera using a surface plasmon resonance biosensor Inflammation and lipoperoxidation in mucopolysaccharidoses type II patients at diagnosis and post-hematopoietic stem cell transplantation. Multidisciplinary approach to redefining thyroid hormone reference intervals with big data analysis Relationship between analytical imprecision and coefficient of determination (R2) of the calibration curve
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1